eli lilly tirzepatide direct to consumer Lowers Cost of Single-Dose Zepbound Vials Eli Lilly, the maker of

Tirzepatide, a glucagon-like peptide-1 receptor agonist GLP-1 RA affects the gastrointestinal system by slowing down the emptying of the stomach

In addition to stimulating the GLP-1 receptor, tirzepatide also activates the GIP receptor

So being off by 5 units means being off by 1mg

Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners